CDX2is an amplified lineage-survival oncogene in colorectal cancer
- 29 October 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (46), E3196-E3205
- https://doi.org/10.1073/pnas.1206004109
Abstract
The mutational activation of oncogenes drives cancer development and progression. Classic oncogenes, such as MYC and RAS, are active across many different cancer types. In contrast, “lineage-survival” oncogenes represent a distinct and emerging class typically comprising transcriptional regulators of a specific cell lineage that, when deregulated, support the proliferation and survival of cancers derived from that lineage. Here, in a large collection of colorectal cancer cell lines and tumors, we identify recurrent amplification of chromosome 13, an alteration highly restricted to colorectal-derived cancers. A minimal region of amplification on 13q12.2 pinpoints caudal type homeobox transcription factor 2 (CDX2), a regulator of normal intestinal lineage development and differentiation, as a target of the amplification. In contrast to its described role as a colorectal tumor suppressor, CDX2 when amplified is required for the proliferation and survival of colorectal cancer cells. Further, transcriptional profiling, binding-site analysis, and functional studies link CDX2 to Wnt/β-catenin signaling, itself a key oncogenic pathway in colorectal cancer. These data characterize CDX2 as a lineage-survival oncogene deregulated in colorectal cancer. Our findings challenge a prevailing view that CDX2 is a tumor suppressor in colorectal cancer and uncover an additional piece in the multistep model of colorectal tumorigenesis.Keywords
This publication has 66 references indexed in Scilit:
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasNature Genetics, 2009
- CDK8 is a colorectal cancer oncogene that regulates β-catenin activityNature, 2008
- Variation in Homeodomain DNA Binding Revealed by High-Resolution Analysis of Sequence PreferencesCell, 2008
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- Patterns of somatic mutation in human cancer genomesNature, 2007
- GenePattern 2.0Nature Genetics, 2006
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- Insulin-promoter-factor 1 is required for pancreas development in miceNature, 1994